Stay updated on Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial
Sign up to get notified when there's something new on the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page.

Latest updates to the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe NIH terminology-transition notice about using “Super Intelligence” alongside “Artificial Intelligence” is no longer displayed at the top of the page.SummaryDifference1%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0; the study page remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial page itself continues to display a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error with a standard header, and the visible study-record content has been removed (investigators, locations, eligibility criteria, and study details).SummaryDifference19%

Stay in the know with updates to Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tetravalent Dengue Vaccine in Adults Clinical Trial page.